Palisade Bio, Inc. (Nasdaq: PALI), a clinical-stage biopharmaceutical company, will participate in a virtual fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium. The event is scheduled for Thursday, February 12, 2026, from 1:30 PM to 1:55 PM ET. JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President and Chief Medical Officer, will represent the company during the session. A live webcast of the presentation will be accessible on the Events page in the Investors section of the Company's website at palisadebio.com, with a replay available following the live event and archived for a limited time. Access the webcast here.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9650942-en) on February 09, 2026, and is solely responsible for the information contained therein.